Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




AI Model Could Use ECG Tests to Detect Premature Aging and Cognitive Decline

By HospiMedica International staff writers
Posted on 25 Feb 2025

Stroke can accelerate age-related cognitive decline, impacting an individual's quality of life and daily functioning. More...

An electrocardiogram (ECG) records the electrical activity of the heart, with each beat generating an electrical impulse, or "wave," that travels through the heart. According to preliminary findings of a study presented at the American Stroke Association’s International Stroke Conference 2025, ECGs, combined with an artificial intelligence (AI) model, may eventually help detect signs of premature aging and cognitive decline.

Researchers at UMass Chan Medical School (Worcester, MA, USA) have developed an AI model, referred to as a deep neural network (DNN), designed to estimate individuals’ biological age—reflecting the age of their body’s cells and tissues—using ECG data. Unlike chronological age, which counts the number of years a person has lived, ECG-age provides an assessment of the heart’s functional health and potentially the overall condition of the body at the tissue level, offering valuable insights into aging and health. Previous studies have shown that ECG-age can predict the likelihood of heart disease and mortality. However, prior to this new study, the link between ECG-age and cognitive decline was not well understood.

The researchers analyzed data from over 63,000 participants in the UK Biobank, a large-scale ongoing study that includes more than 500,000 volunteers from the UK, all of whom enrolled between the ages of 40 and 69. Participants completed a variety of cognitive tests, which were analyzed in relation to their ECG testing, ensuring the cognitive data reflected the participants' mental status at the same time their ECG-age was calculated. Based on comparisons between actual ages and ECG-age, participants were categorized into three groups: normal aging, accelerated ECG-aging (those with an ECG-age older than their chronological age), and decelerated ECG-aging (those with an ECG-age younger than their chronological age). The findings revealed that individuals in the accelerated ECG-aging group performed worse on 6 of the 8 cognitive tests, while those in the decelerated ECG-aging group performed better on 6 of the 8 cognitive tests, compared to those with normal aging based on their ECG-age.

“There is a lot of ECG-data available for stroke treatment and I encourage health care professionals to use this data to look for signs of cognitive decline. Doing so may help with early diagnosis and timely intervention,” said Bernard Ofosuhene, B.A., lead author of the study and clinical research coordinator in the department of medicine at the UMass Chan Medical School.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.